HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.

Abstract
Dominant-negative TGF-β receptor II (dnTGF-βRII) mice spontaneously develop an autoimmune cholangitis resembling human primary biliary cirrhosis (PBC). Interestingly, the dominant-negative TGF-β receptor is expressed by both CD4(+) and CD8(+) T cells and leads to greatly reduced (but not absent) TGF-β signaling resulting in T cell intrinsic cell mediated autoimmunity. However, the mechanisms of the T cell dysregulation remain unclear. Recently it has been shown that TGF-β signaling is intimately involved with miRNA biogenesis and control. Herein we show that lack of T cell TGF-β signaling leads to down regulation of T cell miRNAs but up-regulation of the key inflammatory miRNA 21. Furthermore, the expression of miR-21 from hepatic effector CD8(+) T cells is significantly higher than in the same subsets isolated from spleen and mesenteric lymph nodes of the dnTGF-βRII mice. Previous studies indicate that miR-21 increases the synthesis of IFN-γ and IL-17A by T cells and suppresses apoptosis via programmed cell death protein 4 (PDCD4). Data presented herein demonstrate that transfecting w.t. B6 T cell subsets with miR-21 resulted in up-regulation of the inflammatory cytokines TNF-α and IFN-γ, thus partly replicating the dnTGF-βRII T cell phenotype. In conclusion, these data suggest miR-21 plays a critical role in the production of pro-inflammatory cytokines in dnTGF-βRII mice, which could be a contributing factor for the development of the organ-specific autoimmune cholangitis and colitis in this murine model of human PBC.
AuthorsYugo Ando, Guo-Xiang Yang, Thomas P Kenny, Kazuhito Kawata, Weici Zhang, Wenting Huang, Patrick S C Leung, Zhe-Xiong Lian, Kazuichi Okazaki, Aftab A Ansari, Xiao-Song He, Pietro Invernizzi, William M Ridgway, Qianjin Lu, M Eric Gershwin
JournalJournal of autoimmunity (J Autoimmun) Vol. 41 Pg. 111-9 (Mar 2013) ISSN: 1095-9157 [Electronic] England
PMID23395552 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Apoptosis Regulatory Proteins
  • Cytokines
  • Inflammation Mediators
  • Interleukin-17
  • MIRN21 microRNA, mouse
  • MicroRNAs
  • Pdcd4 protein, mouse
  • RNA-Binding Proteins
  • Receptors, Transforming Growth Factor beta
  • Interferon-gamma
  • Protein Serine-Threonine Kinases
  • Receptor, Transforming Growth Factor-beta Type II
Topics
  • Animals
  • Apoptosis Regulatory Proteins (immunology, metabolism)
  • Autoimmune Diseases (genetics, immunology, metabolism)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Cholangitis (genetics, immunology, metabolism)
  • Cytokines (immunology, metabolism)
  • Flow Cytometry
  • Gene Expression (immunology)
  • Humans
  • Inflammation Mediators (immunology, metabolism)
  • Interferon-gamma (immunology, metabolism)
  • Interleukin-17 (immunology, metabolism)
  • Liver (immunology, metabolism, pathology)
  • Liver Cirrhosis, Biliary (genetics, immunology, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • MicroRNAs (genetics, immunology)
  • Protein Serine-Threonine Kinases (genetics, immunology, metabolism)
  • RNA-Binding Proteins (immunology, metabolism)
  • Receptor, Transforming Growth Factor-beta Type II
  • Receptors, Transforming Growth Factor beta (genetics, immunology, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: